Document is current
Any future updates will be listed below
-
Authors
Morieri, Mario Luca http://orcid.org/0000-0001-6864-0547
Longato, Enrico
Di Camillo, Barbara
Sparacino, Giovanni
Avogaro, Angelo
Fadini, Gian Paolo http://orcid.org/0000-0002-6510-2097
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 1 December 2022
First Online: 9 December 2022
Declarations
:
: According to local and national regulations on retrospective studies, the protocol was notified and cleared by the Ethics Committee of the University Hospital of Padova and all patients gave their written informed consent to the re-use of clinical data for research purposes. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
: not applicable.
: MLM received lecture fees, or advisory board fees from Servier, Eli Lilly, Novo Nordisk, Merck Sharp & Dohme, and Mylan, AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda. GPF received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp-Dome, Mundipharma, Novartis, Novo Nordisk, Sanofi, Servier. EL, LT, BDC, GS, have nothing to disclose.
